Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)

NCT00291525 is registered in ClinicalTrials.gov with On-X Life Technologies, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00291525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)
Lead sponsor
On-X Life Technologies, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 6, 2006
Completion date
December 29, 2023
Enrollment
977 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

heart valve disease